Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 5, 2011, Pages 478-482

  ONeill, Michael ^d   Heron, Dwight E ^a,b,d   Flickinger, John C ^a,d   Smith, Ryan ^a   Ferris, Robert L ^a,b,d   Gibson, Michael ^c  

^a Departments of Radiation Oncology   (United States)

^b Departments of Otolaryngology   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

intensity modulated radiotherapy; outcome measures; quality of life; xerostomia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MASTICATION; PAIN; QUALITY OF LIFE; RADIATION DOSE; SALIVA; SCORING SYSTEM; SWALLOWING; TASTE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053360039     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181f4759c     Document Type: Article

References (17)

1. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-587. (Pubitemid 29462636)
2. Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006;107:2525-2534. (Pubitemid 44845604)
3. Van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, et al. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol. 2008;3:41.
4. Weymuller EA Jr, Alsarraf R, Yueh B, et al. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg. 2001;127:489-493. (Pubitemid 32434043)
5. Blanco AI, Chao KS, El Naqa I, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055-1069. (Pubitemid 40884418)
6. Munter MW, Karger CP, Hoffner SG, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys. 2004;58:175-184. (Pubitemid 38010351)
7. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck. 2001; 23:201-213. (Pubitemid 32193215)
8. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63:725-731. (Pubitemid 41400058)
9. Scrimger R, Kanji A, Parliament M, et al. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy. Am J Clin Oncol. 2007;30:271-277. (Pubitemid 46884147)
10. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004; 58:663-673. (Pubitemid 38221119)
11. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet-and speech-related quality of life. Int J Radiat Oncol Biol Phys. 2007;68:750-757. (Pubitemid 46818749)
12. Jha N, Seikaly H, McGaw T, et al. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys. 2000;46:7-11. (Pubitemid 30021472)
13. Fisher J, Scott C, Scarantino CW, et al. Phase III quality-of-life study results: impact on patients quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. Int J Radiat Oncol Biol Phys. 2003;56:832-836. (Pubitemid 36677379)
14. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507-1515. (Pubitemid 29254110)
15. Wilson IB. Clinical understanding and clinical implications of response shift. Soc Sci Med. 1999;48:1577-1588. (Pubitemid 29254115)
16. List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17:1020-1028. (Pubitemid 29109336)
17. Nguyen NP, Sallah S, Karlsson U, et al. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer. 2002;94:1131-1141. (Pubitemid 34150869)